Many of us who have suffered incomplete recovery following a bout with GBS may have a new treatment option. The aim of this clinical trial using Eculizumab is to improve recovery and limit residual symptoms from GBS. Please read the report here for more details: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30114-5/fulltext